Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis

Karin Allenspach, Andreas Handel, Stanley Marks, Peter Kook, Kenny Simpson, Joseph Bartges, Kenjiro Fukushima, Aarti Kathrani, Silke Salavati, Julien Dandrieux, Caroline Mansfield, Alison Manchester, Craig Webb, Valerie Freiche, W Zane Billings, Jonathan P Mochel

Research output: Contribution to journalLetterpeer-review

Abstract / Description of output

We read with interest the article by Steiner et al,1 that claims that administration of fuzapladib is safe and effective in reducing 2 clinical scores in dogs with acute pancreatitis (AP). We commend Steiner et al for their efforts in addressing a critical need in veterinary medicine. This letter, however, raises significant concerns regarding the methodology and interpretation of the study results.
Original languageEnglish
Pages (from-to)1282-1284
Number of pages3
JournalJournal of Veterinary Internal Medicine
Volume38
Issue number3
Early online date5 Mar 2024
DOIs
Publication statusE-pub ahead of print - 5 Mar 2024

Keywords / Materials (for Non-textual outputs)

  • Animals
  • Dog Diseases/diagnosis
  • Dogs
  • Pancreatitis/veterinary
  • Randomized Controlled Trials as Topic

Fingerprint

Dive into the research topics of 'Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis'. Together they form a unique fingerprint.

Cite this